Aurinia Pharmaceuticals Inc AUPH
$15.47
+1.91%
at last close
Financials (TTM)
- Revenue
- $311.51 million
- Net Income
- $314.11 million
- Net Margin
- 100.84%
- Return on Equity
- 51.09%
- Debt-to-Equity
- —
- P/E Ratio
- 6.76
- Price / Book
- 3.34
- Price / Sales
- 6.60
Over the trailing twelve months, Aurinia Pharmaceuticals Inc generated revenue of $311.51 million and net income of $314.11 million, a net margin of 100.84%.
At the last closing price of $15.47, AUPH trades at 6.76 times trailing earnings and 6.60 times sales, with a market capitalization of $2.06 billion.
Key Stats
- Last Close
- $15.47
- Market Cap
- $2.06 billion
- 52-Week Range
- $8.28 – $19.25
- Average Volume
- 1.23 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.